Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alfresa HoldingsTSE:2784 +0.21%83 Pretax Margin % is 1.98% as of Mar. 2026, which is 9% above its 10-year median of 1.81. GuruFocus rates TSE:2784 with a GF Score™ of 83/100 and a GF Value™ of 円2,542.44 (Fairly Valued). The stock has 1 warning sign investors should review. Among 119 Medical Distribution companies, Alfresa Holdings ranks worse than 53.78% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Alfresa Holdings Pretax Margin % Related Terms
Alfresa Holdings Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Alfresa Holdings's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2784 vs MCK, COR, CAH: Pretax Margin % Comparison
For the Medical Distribution subindustry, Alfresa Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alfresa Holdings Pretax Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Alfresa Holdings's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alfresa Holdings (TSE:2784) has a Pretax Margin % of 1.98% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Alfresa Holdings and its competitors. This is near median its historical median of 1.81. Over the past decade, Alfresa Holdings' Pretax Margin % has ranged from 1.33 to 2.32. According to the industry distribution chart, Alfresa Holdings ranks #64 out of 119 companies in the Medical Distribution industry, placing it in the top 53.8%.
Is Alfresa Holdings' Pretax Margin % too high?
Alfresa Holdings' current Pretax Margin % of 1.98% is near median its 10-year median of 1.81. Over the past 10 years, this metric has ranged from a low of 1.33 to a high of 2.32. The Medical Distribution industry median Pretax Margin % is 2.18. Alfresa Holdings' value of 1.98% is 9.2% below this industry median. Based on the distribution chart, Alfresa Holdings ranks #64 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Alfresa Holdings has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Pretax Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #64 out of 119 companies for Pretax Margin %. This places Alfresa Holdings in the lower half of its industry. The industry median Pretax Margin % is 2.18. Alfresa Holdings' value of 1.98% is 9.2% below this benchmark. Historically, Alfresa Holdings' own Pretax Margin % has ranged from 1.33 to 2.32 over the past decade. While the company's 10-year median is 1.81 vs. the industry median of 2.18, Alfresa Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Distribution company?
The median Pretax Margin % among Medical Distribution companies is 2.18, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alfresa Holdings's current Pretax Margin % of 1.98% is 9.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Alfresa Holdings and its competitors. For the Medical Distribution industry, the median Pretax Margin % is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alfresa Holdings's current Pretax Margin % is 1.98%, which is near median its own 10-year median of 1.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (TSE:2784) is currently considered Fairly Valued. The stock's GF Value™ is 円2,542.44, compared to a current price of 円2,414.00 — trading 5.1% below its estimated fair value. The current Pretax Margin % is 1.98%, which is near median its 10-year median of 1.81 and 9.2% below the Medical Distribution industry median of 2.18. Alfresa Holdings' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Alfresa Holdings (TSE:2784), the current Pretax Margin % is 1.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alfresa Holdings (TSE:2784) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of 円2,414.00 is trading 5.1% below its estimated GF Value™ of 円2,542.44.
GuruFocus considers Alfresa Holdings to be Fairly Valued.
Key valuation signals for TSE:2784:
Pretax Margin %: 1.98% (near median its 10-year median of 1.81)
GF Value™: 円2,542.44 vs. price of 円2,414.00 (5.1% below fair value)
Industry Position: 9.2% below the Medical Distribution median (#64 of 119)
No single metric tells the full story. See the TSE:2784 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
83GF Score
Get the complete analysis for TSE:2784
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2784 has been successfully added to your 
